Discover the most-read SMA stories of 2025, featuring updates on the gene therapy Zolgensma, next-generation treatments, and ...

Leuprorelin acetate, a medicine approved in the U.S. for prostate cancer, may slow the progression of SMA type SBMA, ...

Columnist Connie Chandler offers a message of courage and hope for those spending this season in a hospital bed.

This Christmas, columnist Ari Anderson gives thanks that some health complications he experienced post-surgery resolved on ...

A new review of studies reveals that incorporating SMA into newborn screening programs yields clinical improvements and ...

Columnist Ari Anderson pays tribute to his mom, who excels at many roles, including advocate, manager, teacher, and caregiver ...

Sixteen years after her daughter's diagnosis of SMA type 1, guest columnist Cherie Ehlert is no longer counting the months, ...

Cherie Ehlert lives in Vancouver, British Columbia, Canada. She is a disability advocate and created “Charlie's Angels” to ...

Disability life coaching is turning out to be just the balm columnist Brianna Albers needed to recall the importance of community in SMA.

Fatigue in the diaphragm may contribute to breathing issues in people with spinal muscular atrophy, a new study reports.

SMA gene therapy Zolgensma safely improved motor function in children with SMA who needed tracheostomy, a real-world study ...